PacBio Says It Will 'Vigorously' Defend Against Helicos' Patent Infringement Claims

"Helicos' patents are directed to methods used in their second-generation 'flush and scan' system, and even at that, do not represent the earliest publication of those concepts," said PacBio chairman and CEO Hugh Martin in a statement.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.